3 Results for "

neurodegenerative condition

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "neurodegenerative condition" in MCE Product Catalog:

Cat. No.: HY-N2410
CAS No.: 66648-43-9
Synonyms: N-feruloyltyramine; Moupinamide
N-trans-Feruloyltyramine (N-feruloyltyramine), an alkaloid, is a potent antioxidant. N-trans-Feruloyltyramine improves H2O2-induced intracellular ROS generation and decreases apoptosis. N-trans-Feruloyltyramine has the potential for oxidative stress-related neurodegenerative conditions and cancer research .
loading...
    loading...
Cat. No.: HY-106432A
CAS No.: 159912-58-0
Purity:  99.86%
Synonyms: SB-202026 hydrochloride; Memric hydrochloride
Target:  

mAChR Dopamine Receptor

Research Areas:  

Neurological Disease

Sabcomeline (SB-202026; Memric) hydrochloride is a muscarinic receptor agonist capable of crossing the blood-brain barrier. Sabcomeline hydrochloride exhibits affinity for all hM1 to hM5 subtypes (pKi=6.72-7.23), and shows near-full agonism at the hM3 receptor, inducing extracellular acidification. Sabcomeline hydrochloride alters the binding kinetics of dopamine D2 receptors through neural network regulation. Sabcomeline hydrochloride also causes minimal cardiovascular changes, effectively reverses spatial memory deficits in rodents and induces conditioned taste aversion. Sabcomeline hydrochloride is an important tool compound in studies of Alzheimer's disease and related neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-N2410R
CAS No.: 66648-43-9
Synonyms: N-feruloyltyramine (Standard); Moupinamide (Standard)
N-trans-Feruloyltyramine (Standard) is the analytical standard of N-trans-Feruloyltyramine. This product is intended for research and analytical applications. N-trans-Feruloyltyramine (N-feruloyltyramine), an alkaloid, is a potent antioxidant. N-trans-Feruloyltyramine improves H2O2-induced intracellular ROS generation and decreases apoptosis. N-trans-Feruloyltyramine has the potential for oxidative stress-related neurodegenerative conditions and cancer research .
loading...
    loading...